These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
392 related items for PubMed ID: 28645983
1. The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale. Bressendorff I, Hansen D, Schou M, Kragelund C, Brandi L. BMJ Open; 2017 Jun 23; 7(6):e016795. PubMed ID: 28645983 [Abstract] [Full Text] [Related]
2. The Effect of Magnesium Supplementation on Vascular Calcification in CKD: A Randomized Clinical Trial (MAGiCAL-CKD). Bressendorff I, Hansen D, Schou M, Kragelund C, Svensson M, Hashemi B, Kristensen T, Vrist MH, Borg R, Tougaard B, Borg K, Hjortkjær HØ, Kristiansen CH, Carlson N, Nasiri M, Ashraf H, Pasch A, Brandi L. J Am Soc Nephrol; 2023 May 01; 34(5):886-894. PubMed ID: 36749131 [Abstract] [Full Text] [Related]
3. Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD. Jovanovich A, Isakova T, Block G, Stubbs J, Smits G, Chonchol M, Miyazaki M. Am J Kidney Dis; 2018 Jan 01; 71(1):27-34. PubMed ID: 28801122 [Abstract] [Full Text] [Related]
6. Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study. Lioufas N, Toussaint ND, Pedagogos E, Elder G, Badve SV, Pascoe E, Valks A, Hawley C, IMPROVE-CKD Writing Committee.. BMJ Open; 2019 Feb 21; 9(2):e024382. PubMed ID: 30796122 [Abstract] [Full Text] [Related]
7. Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial. Lioufas NM, Pedagogos E, Hawley CM, Pascoe EM, Elder GJ, Badve SV, Valks A, Toussaint ND, on behalf of the IMPROVE-CKD Investigators. Am J Nephrol; 2020 Feb 21; 51(3):201-215. PubMed ID: 32023606 [Abstract] [Full Text] [Related]
9. Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. Bundy JD, Cai X, Scialla JJ, Dobre MA, Chen J, Hsu CY, Leonard MB, Go AS, Rao PS, Lash JP, Townsend RR, Feldman HI, de Boer IH, Block GA, Wolf M, Smith ER, Pasch A, Isakova T, CRIC Study Investigators. Am J Kidney Dis; 2019 Jun 21; 73(6):806-814. PubMed ID: 30935773 [Abstract] [Full Text] [Related]
15. Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial. Witham MD, Lees JS, White M, Band M, Bell S, Chantler DJ, Ford I, Fulton RL, Kennedy G, Littleford RC, McCrea IV, McGlynn D, Panarelli M, Ralston MR, Rutherford E, Severn A, Thomson N, Traynor JP, Struthers AD, Wetherall K, Mark PB. J Am Soc Nephrol; 2020 Oct 21; 31(10):2434-2445. PubMed ID: 32817311 [Abstract] [Full Text] [Related]
16. Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients. Chen Z, Qureshi AR, Ripsweden J, Wennberg L, Heimburger O, Lindholm B, Barany P, Haarhaus M, Brismar TB, Stenvinkel P. Bone; 2016 Nov 21; 92():50-57. PubMed ID: 27519971 [Abstract] [Full Text] [Related]
17. Relationship of coronary artery calcification with renal function decline and mortality in predialysis chronic kidney disease patients. Lamarche MC, Hopman WM, Garland JS, White CA, Holden RM. Nephrol Dial Transplant; 2019 Oct 01; 34(10):1715-1722. PubMed ID: 30010904 [Abstract] [Full Text] [Related]